loader
Please Wait
Applying Filters...
FDA_Warning_Letters, Import_Alerts_&_EU_Non-Compliances_in_2019
X

Regeneron Pharmaceuticals's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations aggregated by PharmaCompass

Client EmailClient Virtual Booth
Left Arrow
Right Arrow
Filters Filter
×
FILTER DATA :

filter

REGENERON PHARMACEUTICALS

filter

AFLIBERCEPT

CEMIPLIMAB-RWLC

DUPILUMAB

RILONACEPT

filter

INJECTABLE; INJECTION

INJECTABLE;INTRAVENOUS

VIAL; SINGLE-USE

filter

150MG/ML

220MG

350MG

40MG/ML

filter

USA

INJECTABLE; INJECTION
40MG/ML
EYLEA
USA
125387
INJECTABLE;INTRAVENOUS
350MG
LIBTAYO
USA
761097
INJECTABLE; INJECTION
150MG/ML
DUPIXENT
USA
761055
VIAL; SINGLE-USE
220MG
ARCALYST
USA
125249

PharmaCompass >>

First
Previous
Next
Last